| Literature DB >> 27508392 |
Ling-Jun Li1,2, Peng Guan Ong1, Marjorelee T Colega3, Chad Yixian Han4, Ling Wei Chen5,6,7, Ryan Man Eyn Kidd1, Ecosse Lamoureux1,2, Peter Gluckman5, Kenneth Kwek8, Yap Seng Chong3,9, Seang Mei Saw1,10, Keith M Godfrey11, Tien Yin Wong1,2, Mary Chong Foong-Fong3,5,6.
Abstract
BACKGROUND: Imbalanced macronutrient intakes can induce impairment of endothelial and vascular function, and further lead to metabolic and cardiovascular disease. However, little is known about the influence of such diets on endothelial and vascular dysfunction in pregnant women, even though high-fat diet is a known risk for pregnancy complications such as gestational diabetes and pre-eclampsia.Entities:
Mesh:
Year: 2016 PMID: 27508392 PMCID: PMC4979959 DOI: 10.1371/journal.pone.0160704
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Image of SIVA grading platform.
Retinal microvasculature assessment on the grading platform. A screenshot of a computer-assisted program for measurement of new geometrical retinal vascular parameters from retinal fundus photograph. Zone C is marked in SIVA software by 0.5 to 2.0 optic disc diameter away from the margin of optic disc, respectively. All retinal arterioles and venules larger than 25 μm are marked and assessed within zone C.
Fig 2Examples of retinal venular assessment from two subjects with different diet quality.
Subject in Fig 2a in the upper panel has a unhealthier diet pattern than the subject in Fig 2b. in the lower panel. Comparisons between 2a and 2b are listed below: total mono-unsaturated fat (MUFA) percentage—80.25% vs. 13.45%; total fat intake percentage– 41.8% vs. 36.9%; Health Eating Index for Asian Pregnant Women (HEI-AP)– 27.20 vs. 38.70; central retinal venular equivalent (CRVE)– 180.50 μm vs 145.63 μm.
Comparison of baseline characteristics between participants included and excluded in the study.
| Characteristics | Participants | p value | |
|---|---|---|---|
| attended | not attended | ||
| (n = 614) | (n = 549) | ||
| (mean, SD) | (mean, SD) | ||
| Age, years | 30.49, 5.45 | 31.29, 4.86 | |
| Ethnicity, Chinese | 49.59 | 58.39 | |
| Maternal Education, University | 24.27 | 39.05 | |
| Hypertension history, Yes % | 1.96% | 2.55% | 0.61 |
| Diabetes history, Yes % | 0.98% | 2.01% | 0.27 |
| weight before pregnancy, Kg | 56.93, 11.95 | 56.89, 11.16 | 0.90 |
| BMI at 26–28 weeks’ pregnancy, Kg/m2 | 26.32, 4.49 | 26.00, 4.86 | 0.26 |
| 37.91% | 40.23% | 0.43 | |
| CRAE, μm | 120.89, 9.01 | 120.47, 8.30 | 0.58 |
| CRVE, μm | 171.33, 12.54 | 169.95, 12.69 | 0.21 |
*Statistical analysis was performed either by student’s t-test or χ2 test.
Basic characteristic in categories in relation to retinal vascular caliber in the GUSTO cohort.
| Variables | CRAE, μm | p trend | CRVE, μm | p trend |
|---|---|---|---|---|
| mean, SD | mean, SD | |||
| Age | ||||
| < 35 years (n = 461) | 121.24, 8.88 | 0.17 | 172.49, 12.60 | |
| ≧ 35 years (n = 153) | 120.08, 9.46 | 168.16, 12.31 | ||
| Ethnicity | ||||
| Chinese (n = 317) | 120.00, 9.10 | 169.21, 12.39 | 0.08 | |
| Malay (n = 187) | 121.59, 8.98 | 175.00, 12.86 | ||
| Indian (n = 110) | 122.63, 8.66 | 171.64, 11.71 | ||
| History of hypertension | ||||
| Yes (n = 12) | 114.72, 11.97 | 166.40, 17.40 | 0.17 | |
| No (n = 602) | 121.08, 8.93 | 171.51, 12.54 | ||
| History of Type 2 Diabetes | ||||
| Yes (n = 6) | 123.65, 6.73 | 0.46 | 171.35, 12.67 | 0.25 |
| No (n = 608) | 120.93, 9.05 | 171.33, 11.01 | ||
| Pre-pregnancy overweight or obese status | ||||
| Yes ≧ 25.00 kg/m2 (n = 213) | 119.47, 9.00 | 171.23, 12.87 | 0.97 | |
| No < 25.00 kg/m2 (n = 353) | 121.75, 8.92 | 171.27, 12.64 | ||
| weight gain, mean = 8.45 kg | ||||
| ≤ 50 centile (n = 267) | 120.80, 8.79 | 0.89 | 169.82, 12.40 | |
| > 50 centile (n = 282) | 120.91, 9.12 | 172.29, 12.82 | ||
| Parity | ||||
| Primiparous (n = 253) | 121.86, 8.62 | 173.77, 12.42 | ||
| at least 1 live birth history (n = 357) | 120.28, 9.27 | 169.65, 12.50 | ||
P trend was calculated by factor regression.
Abbreviation: CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent.
Associations between health eating index (HEI), total energy intakes and retinal vascular caliber among pregnant women during 26–28 weeks’ gestation.
| Retinal vessels | HEI-AP | Total energy intake | ||
|---|---|---|---|---|
| Each 20 scores ↓ | Each 1.0 kcal ↑ | |||
| Model 1 | 2.02, 1.14 | 0.08 | 2.50, 2.60 | 0.34 |
| Model 2 | 1.70, 1.12 | 0.13 | 3.66, 2.60 | 0.16 |
| Model 3 | 1.72, 1.20 | 0.15 | 3.59, 2.76 | 0.19 |
| Model 1 | 2.48, 0.80 | -2.23, 1.86 | 0.23 | |
| Model 2 | 1.58, 0.80 | -1.03, 1.89 | 0.59 | |
| Model 3 | 1.70, 0.86 | -1.24, 1.99 | 0.53 | |
Abbreviation: SE, standard error, CI, confidence interval; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; HEI-AP, Healthy Eating Index for Asian Pregnant women.
Model 1, unadjusted
Model 2, adjusted for age and ethnicity.
Model 3, Model 2 and additionally adjusted for history of hypertension, history of diabetes, pre-pregnancy overweight or obese status, weight gain at 26–28 weeks and primiparous status.
Associations between Macronutrients percentage and retinal vascular caliber among pregnant women during 26–28 weeks’ gestation.
| Retinal vessels | Total protein % | Total fat % | Total carbohydrates % | |||
|---|---|---|---|---|---|---|
| Each 0.1 unit ↑ in log | Each 0.1 unit ↑ in log | Each 0.1 unit ↑ in log | ||||
| Model 1 | -0.47, 0.34 | 0.17 | 0.29, 0.32 | 0.47 | 0.17, 0.46 | 0.72 |
| Model 2 | -0.25, 0.34 | 0.46 | 0.39, 0.32 | 0.22 | -0.14, 0.46 | 0.77 |
| Model 3 | -0.17, 0.35 | 0.64 | 0.25, 0.33 | 0.45 | -0.01, 0.47 | 0.98 |
| Model 4 | -0.17, 0.36 | 0.63 | -- | -- | 0.89, 0.88 | 0.31 |
| Model 5 | -0.16, 0.40 | 0.70 | 0.68, 0.63 | 0.29 | -- | -- |
| Model 6 | -- | -- | 0.15, 0.35 | 0.66 | 0.01, 0.55 | 0.99 |
| Model 1 | -0.82, 0.47 | 0.08 | 0.37, 0.44 | 0.41 | 0.43, 0.64 | 0.50 |
| Model 2 | -0.55, 0.47 | 0.24 | 0.51, 0.44 | 0.24 | 0.01, 0.64 | 0.88 |
| Model 3 | -0.57, 0.49 | 0.24 | 0.42, 0.46 | 0.36 | 0.11, 0.66 | 0.87 |
| Model 4 | -0.63, 0.49 | 0.20 | -- | -- | 2.17, 1.21 | 0.07 |
| Model 5 | -0.73, 0.56 | 0.19 | 1.84, 0.88 | -- | -- | |
| Model 6 | -- | -- | 0.58, 0.48 | 0.23 | -0.44, 0.76 | 0.56 |
Abbreviation: SE, standard error; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent.
Model 1: unadjusted
Model 2: adjusted for age and ethnicity.
Model 3: includes Model 2 and additionally adjusted for history of hypertension, history of diabetes, pre-pregnancy overweight or obese status, weight gain at 26–28 weeks and primiparous status.
Model 4: includes Model 3 and additionally adjusted for total energy intake and total fat intake percentage.
Model 5: includes Model 3 and additionally adjusted for total energy intake and total carbohydrate intake percentage.
Model 6: includes Model 3 and additionally adjusted for total energy intake and total protein intake percentage.
Associations between Saturated fat and retinal vascular caliber among pregnant women during 26–28 weeks’ gestation.
| Retinal Vessels | Saturated Fat%, | MUFA %, | PUFA % | |||
|---|---|---|---|---|---|---|
| each 0.1 unit ↑ in log | each 0.1 unit ↑ in log | each 0.1 unit ↑ in log | ||||
| Model 1 | -0.01, 0.38 | 0.99 | 0.19, 0.43 | 0.67 | -0.08, 0.23 | 0.72 |
| Model 2 | -0.15, 0.39 | 0.69 | 0.43, 0.44 | 0.32 | -0.05, 0.23 | 0.83 |
| Model 3 | -0.30, 0.41 | 0.47 | 0.72, 0.45 | 0.11 | 0.12, 0.25 | 0.64 |
| Model 7 | -- | -- | 0.71, 0.46 | 0.12 | -0.01, 0.38 | 0.80 |
| Model 8 | -0.32, 0.42 | 0.45 | -- | -- | 0.30, 0.27 | 0.26 |
| Model 9 | -0.55, 0.62 | 0.38 | 0.94, 0.54 | 0.08 | -- | -- |
| Model 1 | 0.41, 0.54 | 0.44 | 1.01, 0.60 | 0.10 | -0.48, 0.32 | 0.14 |
| Model 2 | -0.15, 0.53 | 0.78 | 1.55, 0.60 | -0.28, 0.31 | 0.37 | |
| Model 3 | -0.25, 0.56 | 0.66 | 1.82, 0.62 | -0.29, 0.35 | 0.41 | |
| Model 7 | -- | -- | 1.84, 0.63 | -0.82, 0.53 | 0.13 | |
| Model 8 | -0.15, 5.81 | 0.80 | -- | 0.07, 0.38 | 0.85 | |
| Model 9 | -1.35,0.87 | 0.12 | 1.76, 0.75 | -- | -- | |
Abbreviation: MUFA, mono-unsaturated fat; PUFA, poly-unsaturated fat; SE, standard error; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent.
Model 1: unadjusted
Model 2: adjusted for age and ethnicity.
Model 3: incluing Model 2 and additionally adjusted for history of hypertension, history of diabetes, pre-pregnancy overweight or obese status, weight gain at 26–28 weeks and primiparous status.
Model 7: including Model 3 and additionally adjusted for total energy intake, total protein intake percentage, total carbohydrates percentage and total saturated fat intake percentage.
Model 8: including Model 3 and additionally adjusted for total energy intake, total protein intake percentage, total carbohydrates percentage and MUFA percentage.
Model 9: including Model 3 and additionally adjusted for total energy intake, total protein intake percentage, total carbohydrates percentage and PUFA percentage.